TrialRenal failure2021

Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial.

Zhaohui Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.